2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Obese Kidney Donors: Impact of Opioid-Minimization Using Ketorolac-Based Pain Management Protocol Following Robotically Assisted, Laparoscopic Living Donor Nephrectomy.

M. Campara, B. Valdepenas, A. Virani, K. Galen, I. Tang, J. Oberholzer, E. Benedetti.
Obesity Is an Important Factor in Deceased but Not Living Donor Kidney Transplants.

A. Asderakis, A. Ilham, U. Khalid, R. Chavez.
Obesity Predicts New-Onset Diabetes After Live Kidney Donation.

K. Lentine,¹ A. Naik,² N. Lam,³ M. Schnitzler,^1,6 H. Xiao,¹ D. Axelrod,⁴ G. Hess,⁵ B. Kasiske,⁶ A. Garg,⁷ S. Gustafson,⁶ D. Brennan,⁸ D. Segev.^9,6
Objective Assessment of Graft Metabolism and Function During Ex Vivo Liver Perfusion.

J. Echeverri,¹ S. Cleland,² M. Kaths,¹ I. Linares,¹ R. Roizales,¹ N. Goldaracena,¹ D. Kollmann,¹ M. Hamar,¹ P. Urbanellis,¹ S. Ganesh,¹ O. Adeyi,³ D. Grant,¹ N. Selzner,⁴ M. Wasowicz,² M. Selzner.¹
Occult Hepatitis C Virus in Recipients of Kidney Transplantation: Prevalence and Clinical Implications.

C. Jimenez,¹ T. Olea,¹ M. Lopez,¹ I. Castillo,² J. Bartolomé,² J. Quiroga,² E. Gonzalez,¹ V. Carreño,² R. Selgas.¹
Omega 3 Attenuates Ischemia Reperfusion Renal Injury via Enhancement of Autophagy Flux.

J.-J. Kim,¹ J. Jeong,² D. Choi,³ K. Na,³ K. Lee.³
On the Pathogenesis of Post-Transplant Diarrhea in Kidney Transplant Recipients.

J. Lee,¹ M. Mcgruder,¹ L. Zhang,¹ M. Thangamani,¹ D. Dadhania,¹ L. Westblade,¹ M. Satlin,¹ A. Robertson,² L. Ling,² Y. Taur,² E. Pamer,² M. Suthanthiran.¹
Once-Daily versus Twice-Daily Tacrolimus in Living Kidney Transplantation: A Multicenter, Parallel Group, Open-Label, 5-Year, Randomized Non-Inferiority Trial.

K. Unagami,¹ M. Okumi,² T. Hirai,² D. Toki,³ H. Shirakawa,⁴ T. Shimizu,² K. Omoto,⁵ M. Inui,³ H. Ishida,² K. Nitta,¹ K. Tanabe.²
One Year Outcomes of Low-Dose vs Very Low-Dose Extended-Release Tacrolimus/Mycophenolate mofetil in De Novo Kidney Transplantation: A Multi-Center Randomized Controlled Trial.

Y. Hidaka,¹ S. Yamanaga,¹ M. Toyoda,¹ S. Narumi,² Y. Watarai,² T. Kobayashi.³
One-Year Graft and Patient Survival of Deceased Donor Kidney Transplants Under KAS.

A. Wilk,¹ D. Stewart,¹ M. Aeder,² A. Kucheryavaya,¹ D. Klassen.¹
Online Patient Resources for Deceased Donor and Live Donor Kidney Recipients: A Comparative Analysis of Readability.

E. Zhou, E. Kiwanuka, W. Cioffi, P. Morrissey.
Operational Tolerance in Intestinal Transplantation: A Proven Possibility.

B. Houlihan,¹ P. Cha,^1,2 C. Cosentino,^1,2 J. Kaiser,^1,2 A. Shukla,¹ J. Hawksworth,^1,2 C. Matsumoto,¹ T. Fishbein,¹ A. Kroemer.¹
Opioid and Opioid Substitution Therapy in Liver Transplant Candidates: A Survey of Center Policies and Practices.

J. Fleming,¹ J. Lai,³ H. Te,² A. Said,⁴ E. Spengler,⁴ S. Rogal.⁵
OPO Performance Metrics: Relationship with Kidney Transplant Program Performance Metrics and Kidney Utilization.

A. Wey, N. Salkowski, B. Kasiske, A. Israni, J. Snyder.
OPO-Wide Waitlist Size and Deceased Donor Kidney Transplant Rate.

S. Zhou,¹ A. Massie,¹ S. Gentry,² D. Segev.¹
Optimal Induction Therapy for Kidney Transplantation in Previous Heart Transplant Recipients: Analysis of OPTN/UNOS Registry.

M. Sampaio, S. Hussain, B. Chopra, K. Sureshkumar.
Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetile Based Immunosuppression in De Novo Kidney Transplant Recipients: 2 Years Outcome.

Y. Watarai,¹ S. Narumi,¹ M. Okada,¹ R. Kimura,¹ K. Hatazoe,¹ K. Futamura,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ T. Kobayashi.²
Optimization of Pancreatic Islet-Like Clusters from hiPSCs for Cell Therapy in Type 1 Diabetes.

G. Pettinato, P. Kyriazis, M. Thompson, M. Koulmanda, R. Fisher.
Optimizing Support for Living Kidney Donors: Insights from a Prospective Study.

D. Dobosz,¹ C. Thiessen,¹ S. Li,¹ K. Yu,¹ J. Gannon,¹ K. Kennedy,³ D. Gray,² A. Mussell,² P. Reese,² E. Gordon,³ S. Kulkarni.¹
Optimizing Survival Outcomes for Advanced Age Patients Undergoing Liver Transplant.

J. Balogh, K. Lunsford, D. Nguyen, E. Gravis, A. Saharia, C. Mobley, S. Gordon Burroughs, O. Cercio, D. Victor, H. Monsour, A. Gaber, R. Ghobrial.
Organs with Extended Cold Ischemia Time May Offer Aged Kidney Transplant Recipients New Options in an Expanded Donor Pool.

M. Postalcioglu,¹ B. Byun,¹ A. Kaze,² A. Siedlecki,¹ E. Milford,² R. Abdi.¹
Ornithine Transcarbamylase Deficiency (OTC) in the Donor Liver, the Importance of Ascertaining the Cause of Death in the Brain Dead Donor.

M. George,¹ G. Thomas,¹ A. Shun,¹ M. Stormon.²
Orthotopic Liver Transplantation of Xenogeneic Livers Repopulated with Autologous Hepatocytes: Proof of Normal Function and Consistent Survival.

G. Oldani, S. Lacotte, L. Orci, V. Delaune, C. Toso.
Outcome After Living Donor Liver Transplantation for Hepatocellular Carcinoma in Elderly Patients > 65 Years: Assessing the Long Term Survival.

A. Thorat, S.-C. Hsu, L.-B. Jeng, H.-R. Yang, P.-C. Li, C.-C. Yeh, T.-H. Chen, K.-S. Poon.
Outcome and Risk Factors of Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplantation.

G. Chen, C. Wang, Z. Wu, J. Zhang, S. Yu, C. Wang, J. Qiu, L. Chen.
Outcome of ABO-Incompatible Kidney Transplantation After Stratified Desensitization.

K. Nanmoku, A. Kurosawa, T. Kubo, T. Shinzato, T. Shimizu, T. Kimura, T. Yagisawa.
Outcome of Adult Living Donor Renal Transplants in Different Era: Analysis of UNOS Database.

V. Whittaker, R. Gruessner, M. Laftavi, Z. Acun, A. Gruessner.
Outcome of Kidney Transplantation from Deceased Octogenarian Donors.

P. Donato, L. Furian, C. Silvestre, F. Neri, C. Di Bella, M. Di Bello, P. Rigotti.
Outcome of Liver Transplantation in Patients with Prior Bariatric Surgery.

M. Safwan,¹ M. Abouljoud,¹ R. Salgia.²
Outcome of Living Donor Transplantation in Pediatric Recipients Over the Last Three Decades by Era: An Analysis of UNOS Database.

V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.
Outcome of Living-Donor Kidney Transplantation in Cross-Match-Positive Recipients at a Single Center.

D. Okada,¹ M. Okumi,¹ K. Unagami,² T. Shimizu,¹ H. Ishida,¹ K. Tanabe.¹
Outcome of Systemic Monitoring of DSA and Protocol Management to Optimize Renal Allograft Outcome in a Single Transplant Center.

S. Chang,¹ I. Mallawaarachchi,² C. Yip,¹ T. Shanahan,³ A. Gundroo,¹ A. Dwivedi,² S. Patel,⁴ M. Zachariah.¹
Outcomes After Cholecystectomy in Patients with End Stage Renal Disease.

I. Olorundare, S. DiBrito, C. Holscher, J. Garonzik-Wang, D. Segev.
Outcomes After Hysterectomy in Patients with End Stage Renal Disease.

I. Olorundare, S. DiBrito, C. Haugen, J. Garonzik-Wang, D. Segev.
Outcomes After Lung Transplant: Being a Teenager Does Not Stop at Age 18.

R. Baker,¹ R. Rizwan,¹ R. Bryant III,¹ M. Schecter,² C. Towe,² J. Tweddell,¹ F. Zafar,¹ D. Morales.¹
Outcomes and Risk Factors for Graft Loss: Lessons Learned from More Than 1,056 Pediatric Kidney tx at a Single Center.

S. Chinnakotla, P. Verghese, B. Chavers, V. Kirchner, J. Najarian.
Outcomes Following Cholecystectomy in Kidney Transplant Recipients.

S. DiBrito, C. Holscher, I. Olorundare, C. Haugen, Y. Alimi, D. Segev, J. Garonzik-Wang.
Outcomes Following Colectomy in Kidney Transplant Recipients.

S. DiBrito, Y. Alimi, C. Holscher, I. Olorundare, D. Segev, J. Garonzik-Wang.
Outcomes Following Colectomy in Liver Transplant Recipients.

S. DiBrito, Y. Alimi, C. Haugen, I. Olorundare, D. Segev, J. Garonzik-Wang.
Outcomes Following Hysterectomy in Kidney Transplant Recipients.

S. DiBrito, I. Olorundare, C. Haugen, C. Holscher, L. Kucirka, D. Segev, J. Garonzik-Wang.
Outcomes Following Reduction of Immunosuppression in Solid Organ Transplant Recipients with Cryptococcosis.

P. Bryant,¹ P. Pappas,¹ C. Huisingh,¹ R. Mannon,¹ J. Locke,¹ K. Wille,¹ D. Eckhoff,¹ J. Tallaj,¹ J. Baddley.^1,2
Outcomes Following Solitary Pancreas Transplantation – Do Steroids Matter?

C. Chan, I. Tang, J. Oberholzer, M. Campara.
Outcomes Following Transplantation for Hepatocellular Carcinoma.

P. Tabrizian, K. Nakazawa, J. Prigoff, M. Schwartz, S. Florman.
Outcomes for Plasma Cell Rich Rejection in Pediatric Kidney Transplant Patients.

O. Moussa, S. Self, K. Twombley.
Outcomes from a Multinational Randomised Controlled Trial Comparing Normothermic Machine Perfusion with Static Cold Storage in Human Liver Transplantation.

D. Nasralla,¹ Consortium for Organ Preservation in Europe Liver Research Group,¹ R. Ploeg,¹ C. Coussios,² P. Friend.¹
Outcomes of 100 ABO Incompatible Kidney Transplants: A Single US Center Experience.

S. Sethi, A. Vo, E. Huang, L. Varanasi, J. Choi, A. Peng, R. Najjar, S. Jordan.
Outcomes of Active Screening for Carbapenem-Resistant Enterobacteriaceae among Liver Transplant Recipients.

T. Bias,¹ G. Malat,¹ D. Lee,² S. Talluri,² K. Ranganna,² S. Epstein,² V. Patel,² S. Guy.³
Outcomes of Combined Liver/Lung Transplantation for Cystic Fibrosis Using SRTR Analysis.

J. Halldorson,¹ K. AlQahtani.²
Outcomes of Deceased Donor Kidney Transplantation in Elderly Recipients Aged 70 Years and Older.

A. Adamusiak,¹ T. Salter,² P. Andrews,² C. Callaghan.¹
Outcomes of Hand Assisted Laparoscopic Right Donor Nephrectomy, Single Center Experience.

A. El-Hinnawi, A. Rajab, R. Pelletier.
Outcomes of Infrainguinal Revascularization in Renal Transplant Patients.

R. Craig-Schapiro, B. Nejim, M. Malas.
Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.

J. Ramirez,¹ H. Aghil,¹ M. Baz,³ B. Sawaya,¹ N. Rajagopalan,² X. Mei,³ R. Gedaly,³ A. El-Husseini.¹
Outcomes of Kidney Transplantation Using Deceased Diabetic Donors.

F. Khan,¹ W. Suki,¹ D. Nguyen,² E. Graviss.²
Outcomes of Moderately to Severely Steatotic Grafts in Liver Transplantation: A Meta-Analysis.

K. Bonner,¹ C. Thongprayoon,² W. Cheungpasitporn,¹ M. Leise.¹
Outcomes of Organs Transplants When the Donor Is a Prior Recipient.

G. Lee,¹ D. Goldberg,² M. Levine,¹ P. Abt.¹
Outcomes of Protocol Allograft Kidney Biopsy in DeNovo Donor Specific Antibodies.

S. Parajuli, P. Reville, T. Ellis, A. Djamali, D. Mandelbrot.
Outcomes of Recurrent Clostridium difficile Infection in Solid Organ Transplant Recipients.

M. Shiotsuka, Y. Natori, D. Kumar, A. Humar, C. Rotstein, S. Husain.
Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience.

T. Kaur, E. Poggio, S. Nurko.
Outcomes with Kidney Transplant from Deceased Donors with Acute Kidney Injury and Prolonged Cold Ischemia Time: UNOS Analysis.

G. Dube, S. Mohan, M. Chiles.
Outcomes with Steroid Avoidance Regimen After Kidney Transplantation without Induction Immunosuppression.

A. Sakhuja,¹ A. Naik,² D. Cibrik,² H. Amer.³
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Dosing.

D. Hesselink,¹ L. Andrews,² B. de Winter,² J. Tang,³ N. Shuker,² R. Bouamar,² R. van Schaik,⁴ B. Koch,² T. Van Gelder.¹

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z